Natural protection from zoonosis by alpha-gal epitopes on virus particles in xenotransmission

Xenotransplantation

Volumn 14, Issue 2, 2007, Pages 104-111

  Kim, Na Young ^a,b   Jung, Woon Won ^c   Oh, Yu Kyung ^d   Chun, Taehoon ^d   Park, Hong Yang ^a   Lee, Hoon Taek ^a   Han, In Kwon ^c   Yang, Jai Myung ^b   Kim, Young Bong ^a  

^a Konkuk University   (South Korea)

^b Sogang University   (South Korea)

^c My Gene Bioscience Institute   (South Korea)

^d Korea University   (South Korea)

Author keywords

gal epitopes; 1 3galactosyltransferase; Complement; Porcine endogenous retrovirus; Vaccinia virus; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; EDETIC ACID; FLUORESCEIN ISOTHIOCYANATE; LECTIN; NEOMYCIN;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STAINING; VACCINIA VIRUS; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; GALACTOSYLTRANSFERASES; GRAFT REJECTION; HELA CELLS; HUMANS; SWINE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES; VACCINIA VIRUS; VIRION; VIRUS REPLICATION; ZOONOSES;

EID: 33947377015     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2007.00377.x     Document Type: Article

References (46)

1. REEMTSMA K, MCCRAKEN BH, SCHLEGEL JU et al. Renal heterotransplantation in man. Ann Surg 1964; 160: 384-410.
2. STARZL TE, MARCHIORO TL, PETERS GN et al. Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 1964; 2: 752-776.
3. PLATT JL. New directions for organ transplantation. Nature 1998; 293: 11-17.
4. DEACON T, SCHUMACHER J, DINSMORE J et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997; 3: 350-353.
5. HUNCHER D, SUN AM, KORBUTT S et al. Bioartificial organs and acceptable risk. Nat Biotechnol 1999; 17: 1045.
6. STARZL TE, FUNG J, TZAKIS A et al. Baboon to human liver transplantation. Lancet 1993; 341: 65-71.
7. FISHMAN JA. Miniature swine as organ donors for man: strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1994; 1: 47-57.
8. SACH DH, SYKES M, ROBSON SC, COOPER DK. Xenotransplantation. Adv Immunol 2001; 79: 129-223.
9. CHAPMAN LE, FOLKS TM, SALOMON DR et al. Xenotransplantation and xenogeneic infections. N Engl J Med 1995; 333: 1498-1501.
10. FISHMAN JA. Xenosis and xenotransplantation; addressing the infectious risks posed by an emerging technology. Kidney Int 1997; 51: 41-45.
11. GROTH CG, KORSGREN O, TIBELL A et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402-1404.
12. GALILI U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480-482.
13. GOOD AH, COOPER DCK, MALCOLM AJ et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559-562.
14. SANDRIN MS, VAUGHAN HA, DABLOWSKI PL, MCKENZIE IFC. Anti-pig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes. Proc Natl Acad Sci U S A 1993; 90: 11391-11395.
15. COLLINS BH, COTTERERLL AH, MCCURRY KR et al. Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. J Immunol 1995; 154: 5500-5510.
16. LARSEN RD, RIVERA-MARRERO C, ERNST LK, CUMMINGS RD, LOWE JB. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal: β-D-Gal(1,4)-D- GlcNAc α(1,3)-galactosyltransferase cDNA. J Biol Chem 1990; 265: 7055-7061.
17. JOZIASSE DH, SHAPER JH, JABS EW, SHAPER NL. Characterization of an alpha1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem 1991; 266: 6991-6998.
18. GALILI U, SHOHET SB, KOBRIN E et al. Man, apes, and old monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 264: 17755-17762.
19. BASU M, BASU S. Enzymatic synthesis of a blood group B-related pentaglycosylceramide by an α-galactosyltransferase from rabbit bone marrow. J Biol Chem 1973; 248: 1700-1706.
20. BETTERIDGE A, WARTKINS WM. Two α-3-D- galactosyltransferases in rabbit stomach mucosa with different acceptor substrate specificities. Eur J Biochem 1983; 132: 29-35.
21. BLANKEN WM, VAN DEN EIJNDEN DH. Biosynthesis of terminal Gal α1-3Galβ1-4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal: N-acetyllactosaminide α1-3galactosyltransferase from calf thymus. J Biol Chem 1985; 260: 12927-12934.
22. HENION TR, MACHER BA, ANARAKI F, GALILI U. Defining the minimal size of catalytically active primate alpha1,3galactosyltransferase: structure-function studies on the recombinant truncated enzyme. Glycobiology 1994; 4: 193-201.
23. JOZIASSE DH. Mammalian glycosyltransferases: genomic organization and protein structure. Glycobiology 1992; 2: 271-277.
24. JOZIASSE DH, SHAPER JH, VAN DEN EIJNDEN DH, VAN TUNEN AJ, SHAPER NL. Bovine alpha1,3-galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem 1989; 264: 14290-14297.
25. LARSEN RD, RAJAN VP, RUFF MM et al. Isolation of a cDNA encoding a murine UDP-galactose: beta-F-galactosyl-1,4-N-acetyl-D- glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer. Proc Natl Acad Sci U S A 1989; 86: 8227-8231.
26. LAI L, KOLBER-SIMONDS D, PARK KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
27. PHELPS CJ, KOIKE C, VAUGHT TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414.
28. MARTIN U, KIESSIG V, BLUSCH JH et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-694.
29. MCKANE BW, RAMACHANDRAN S, YANG J, XU XC, MOHANAKUMAR T. Xenoreactive anti-Galα(1,3)Gal antibodies prevent porcine endogenous retrovirus infection of human in vivo. Hum Immunol 2003; 64: 708-717.
30. QUINN G, WOOD JC, RYAN DJJ et al. Porcine endogenous retrovirus transmission characteristics of galactose α1-3galactose-deficient pig cell. J Virol 2004; 78: 5805-5811.
31. WEISS RA. Transgenic pigs and virus adaptation. Nature 1998; 391: 327-328.
32. WOOD C, KABAT EA, MURPHY LA, GOLDSTEIN IJ. Immunochemical studies of the combining sites of the two isolectins, A4 and B4, isolated from Bandeiraea simplicifolia. Arch Biochem Biophys 1979; 198: 1-11.
33. COOPER DK, GOOD AH, KOREN E et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1: 198-205.
34. ROTHER RP, FODER WL, SPINGHORN JP et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J Exp Med 1995; 182: 1345-1355.
35. TAKEUCHI YC, PORTER CD, STRAHAN KM et al. Sensitization of cells and retroviruses to human serum by α(1-3) galactosyltransferase. Nature 1996; 379: 85-88.
36. COOPER NR. Complement evasion strategies of microorganisms. Immunol Today 1991; 12: 327-331.
37. MORGAN BP. Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci 1995; 32: 265-298.
38. TOMLINSON S. Complement defense mechanisms. Curr Opin Immunol 1993; 5: 83-89.
39. BRYANT RE, JENKINS DE Jr. Calcium requirements for complement dependent hemolytic reactions. J Immunol 1968; 101: 664-668.
40. FINE DP. Comparison of ethylene glycol tetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun 1977; 16: 124-128.
41. SPIRO RG, BHOYROO VD. Occurrence of α-D-galactosyl residues in the thyroglobulins from several species. J Biol Chem 1984; 259: 9858-9866.
42. GALILI U, MANDRELL RE, HAMADEH RM, SHOHET SB, GRIFFISS JM. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730-1737.
43. ORIOL R, YE Y, KOREN E, COOPER DK. Carbohydrate antigens of pig tissue reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-human organ xenotransplantation. Transplantation 1993; 56: 1433-1442.
44. ONIONS D, COOPER DKC, ALEXANDER TJL et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 2000; 7: 143-155.
45. MARGRE S, TAKEUCHI Y, LANGFORD G et al. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-α(1- 3) galactosyl epitope. J Virol 2004; 78: 5812-5819.
46. TAKEUCHI Y, LIONG SH, BIENIASZ PD et al. Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(α1-3)galactosylation. J Virol 1997; 71: 6174-6178.